Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Belite Bio Inc ADR (BLTE)

Belite Bio Inc ADR (BLTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Why Shares of Belite Bio Soared This Week Motley Fool - Fri Jun 30, 2023

The clinical-stage biotech company bounced back from a 52-week low late last week.

AMD : 154.02 (-5.78%)
BLTE : 32.33 (-9.89%)
Why Shares of Belite Bio Are Slumping Wednesday Motley Fool - Wed May 31, 2023

The biopharmaceutical company announced a stock sale that's not great news to current investors.

AMD : 154.02 (-5.78%)
BLTE : 32.33 (-9.89%)
3 Breakout Growth Stocks to Buy for the Long Haul Motley Fool - Mon Jan 9, 2023

These three have had big-time share gains backed up by breakthrough science.

BLTE : 32.33 (-9.89%)
TMDX : 87.86 (-5.84%)
RYTM : 38.45 (-0.18%)
2 Stocks Up 165% and 209% in 2022 That Could Keep Soaring in 2023 Motley Fool - Thu Dec 8, 2022

Find out how these stock rockets could continue their ascent.

BLTE : 32.33 (-9.89%)
TMDX : 87.86 (-5.84%)
3 Soaring Biotech Stocks That Could Climb Much Higher Motley Fool - Thu Oct 20, 2022

These drugmakers have bucked the overall market's downward trend this year and expectations are still high.

BLTE : 32.33 (-9.89%)
CINC : 29.06 (-0.48%)
PLRX : 12.86 (-3.02%)
Author
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers MarketBeat - Tue Oct 4, 2022

Small-cap biotech Catalyst Pharmaceuticals has been outperforming the broader market amid earnings and revenue acceleration. It joined the S&P 600 last month.

SPSM : 39.75 (-0.77%)
CPRX : 16.00 (+2.96%)
CG : 44.63 (-0.95%)
APLS : 48.03 (-7.31%)
AERI : 15.25 (+0.07%)
BLTE : 32.33 (-9.89%)
VRNA : 16.40 (+1.23%)
RVNC : 3.76 (-1.31%)
Belite Bio Reports First Half 2022 Operational Highlights and Financial Results Globe Newswire - Wed Aug 10, 2022

 -LBS-008 (aka Tinlarebant) is Belite Bio’s orally administered tablet for the treatment of Stargardt disease (STGD1) and Dry AMD -A 2-year Phase 2 trial...

BLTE : 32.33 (-9.89%)
Belite Bio to Host Conference Call on August 11, 2022 to Discuss First Half 2022 Financial Results Globe Newswire - Mon Aug 1, 2022

SAN DIEGO, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a San Diego based clinical stage biopharmaceutical drug development company...

BLTE : 32.33 (-9.89%)
Belite Bio Submits Investigational New Drug (IND) Application to FDA for Approval to Proceed with LBS-008 Phase 3 Clinical Trial for the Treatment of Stargardt Disease Globe Newswire - Tue Jul 19, 2022

LBS-008 (a/k/a Tinlarebant) is the Company’s orally administered tablet for the treatment of Stargardt disease (STGD1)There are currently no approved...

BLTE : 32.33 (-9.89%)
Belite Bio Announces Partial Exercise of Over-Allotment Option in Initial Public Offering Globe Newswire - Thu May 12, 2022

SAN DIEGO, May 12, 2022 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite” or the “Company”), a clinical stage biopharmaceutical drug...

BLTE : 32.33 (-9.89%)

Barchart Exclusives

This Outperforming Dividend Aristocrat Could Rally Another 22%, Says Analyst Barchart - Wed Apr 17, 6:30PM CDT
With a track record of 30 years of dividend increases, this industrial stock is also delivering some outsized capital appreciation to shareholders lately. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot